Opentrons is a global provider of lab automation robots and software for biology research, delivering modular robotic systems and no-code tools to automate workflows in life sciences. The company focuses on enabling flexible, scalable automation for workflows such as NGS, proteomics, nucleic acid extraction, PCR, protein purification, and ELISA, with an emphasis on accessible protocol design and a rich protocol library. Headquartered around the United States with a global reach, Opentrons combines hardware, software, and community resources to empower researchers to conduct automated experiments with reduced manual labor and increased reproducibility.
No recent deals for this company.